Static Chart Astellas Pharma Inc. OTC Markets

Stocks

Market Closed - OTC Markets 15:59:27 2026-10-16 EDT			5-day change	1st Jan Change
15.13 ^USD	+1.48%		+5.44%	+13.84%

10-08	Vir Biotechnology's VIR-5500 Gets FDA Fast Track Designation for Prostate Cancer	MT
10-08	Vir Biotechnology, Inc. and Astellas Pharma Inc. Announce FDAFast Track Designation for PSMA-Targeted Pro-XTEN® Dual-Masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer	CI

Duration

Period